AreƱo, Edna L.
HRN: 22-48-70 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/23/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/23/2023
03/30/2023
IV
225mg
Q12HRS
Surgical Site Infection
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes